NCT04742166 (IPAD) is a NA clinical trial of Reconstruction in Surgical Technique, sponsored by Rennes University Hospital.

Who is sponsoring NCT04742166?

NCT04742166 is sponsored by Rennes University Hospital.

What drugs are being tested in NCT04742166?

Interventions in NCT04742166: Reconstruction.

What condition does NCT04742166 study?

NCT04742166 studies Surgical Technique.

Is NCT04742166 still recruiting?

NCT04742166 is currently status unknown. Last updated 28 July 2023.

Last reviewed 2023-07-28 · How we verify

NCT04742166: IPAD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of Side to Side Gastrojejunostomy on the Rate of Delayed Gastric Emptying After Pancreaticoduodenectomy (IPAD)

Status unknown NA Last updated 28 July 2023

What this trial tests

NA trial testing Reconstruction in Surgical Technique in 166 participants. Status unknown.

Timeline

7 July 2021

Primary endpoint
1 October 2024

1 October 2024

Quick facts

Lead sponsor	Rennes University Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	166
Start date	7 July 2021
Primary completion	1 October 2024
Estimated completion	1 October 2024
Sites	2 locations across France

Drugs / interventions tested

Reconstruction

Conditions studied

Surgical Technique — all drugs for Surgical Technique →

Sponsor

Rennes University Hospital

Who can join

18 and older, any sex, with Surgical Technique. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective bi-centric randomized open-label study comparing side to side and end to side gastrojejunostomy in pancreaticoduodenectomy

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Rennes University Hospital trials

Trials by the same sponsor.

NCT07527949 — PASTRAMI : Patient-specific Statistics for Microstructure-augmented Connectomics · NA · not yet recruiting
NCT07449832 — Sperm Epigenome in Hodgkin Lymphoma · NA · not yet recruiting
NCT06950398 — Normothermic Oxygenated Perfusion (NMP) Viability Testing Before Transplantation of Discarded Livers · Phase 2 · not yet recruiting
NCT07188753 — Randomized Controlled Trial Testing the Efficacy of Transcranial Magnetic Stimulation by Accelerated & High-dose Theta-b · NA · not yet recruiting
NCT06898099 — Evaluation of the Efficacy of E2R Hypnotherapy in the Management of Chronic Insomnia in Primary Care (HypERR) · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04742166 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rennes University Hospital
Last refreshed: 28 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04742166.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing